Sumitomo Chemical (SOMMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2023 | 09-2023 | 06-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,877,834 | 1,915,875 | 2,358,878 | 3,547,117 | 3,499,171 |
| Marketable Securities | 243,617 | 282,721 | 243,112 | 244,915 | 291,384 |
| Receivables | 3,869,744 | 4,156,574 | 4,296,160 | 4,908,408 | 5,316,934 |
| Inventories | 5,143,921 | 5,412,540 | 5,944,908 | 5,432,906 | 5,797,663 |
| Other current assets | 488,984 | 498,610 | 675,822 | 742,705 | 506,258 |
| TOTAL | $11,624,100 | $12,266,320 | $13,518,880 | $14,876,050 | $15,411,410 |
| Non-Current Assets | |||||
| PPE Net | 5,816,788 | 5,932,475 | 6,272,386 | 5,894,448 | 6,161,652 |
| Investments And Advances | 5,063,756 | 5,621,216 | 5,468,532 | 5,376,880 | 5,362,567 |
| Intangibles | 4,724,932 | 5,059,521 | 5,256,803 | 4,881,059 | 5,410,044 |
| Other Non-Current Assets | 1,464,044 | 1,370,908 | 1,412,129 | 1,281,073 | 1,364,907 |
| TOTAL | $17,069,520 | $17,984,120 | $18,409,850 | $17,433,460 | $18,299,170 |
| Total Assets | $28,693,630 | $30,250,440 | $31,928,720 | $32,309,520 | $33,710,570 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,549,608 | 3,991,974 | 4,267,295 | 2,724,043 | 2,418,228 |
| Accounts payable and accrued liabilities | 3,375,146 | 3,643,400 | 3,869,475 | 3,904,105 | 4,574,419 |
| Other current liabilities | 1,704,814 | 1,979,044 | 2,205,856 | 2,494,940 | 2,531,066 |
| TOTAL | $9,683,425 | $9,749,693 | $10,454,830 | $9,352,298 | $9,825,494 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,778,029 | 7,321,266 | 7,650,320 | 7,573,258 | 7,610,299 |
| Other Non-Current Liabilities | 1,511,614 | 1,564,844 | 1,775,604 | 1,728,001 | 1,835,951 |
| TOTAL | $9,134,869 | $9,811,421 | $10,159,340 | $10,154,920 | $10,286,720 |
| Total Liabilities | $18,818,290 | $19,561,110 | $20,614,170 | $19,507,220 | $20,112,210 |
| Shareholders' Equity | |||||
| Common Shares | 611,578 | 620,572 | 655,613 | 637,651 | 646,632 |
| Retained earnings | 5,392,522 | 5,605,864 | 6,236,405 | 7,104,708 | 7,475,047 |
| Other shareholders' equity | 3,927,363 | 4,520,001 | 4,483,532 | 4,925,186 | 5,337,075 |
| TOTAL | $9,875,334 | $10,689,320 | $11,314,550 | $12,802,290 | $13,598,360 |
| Total Liabilities And Equity | $28,693,624 | $30,250,430 | $31,928,720 | $32,309,510 | $33,710,570 |